Article Versions Notes

Relave ET, Hedna R, Di Maio A, Devred F, Kovacic H, Robin M, Breuzard G. Therapeutic Contribution of Tau-Binding Thiazoloflavonoid Hybrid Derivatives Against Glioblastoma Using Pharmacological Approach in 3D Spheroids. International Journal of Molecular Sciences. 2024; 25(21):11785. https://doi.org/10.3390/ijms252111785

Relave, Emmanuelle T., Rayane Hedna, Attilio Di Maio, François Devred, Hervé Kovacic, Maxime Robin, and Gilles Breuzard. 2024. "Therapeutic Contribution of Tau-Binding Thiazoloflavonoid Hybrid Derivatives Against Glioblastoma Using Pharmacological Approach in 3D Spheroids" International Journal of Molecular Sciences 25, no. 21: 11785. https://doi.org/10.3390/ijms252111785

Relave, E. T., Hedna, R., Di Maio, A., Devred, F., Kovacic, H., Robin, M., & Breuzard, G. (2024). Therapeutic Contribution of Tau-Binding Thiazoloflavonoid Hybrid Derivatives Against Glioblastoma Using Pharmacological Approach in 3D Spheroids. International Journal of Molecular Sciences, 25(21), 11785. https://doi.org/10.3390/ijms252111785